Jason Okuhara, DO
Interventional Cardiology · Riverview, FLNPI 1215158456
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 50.5% of the total. 2025 is the largest year on record at $399, 2.0 times the $197 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.
Across 61 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$624
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$95
- Medtronic$80
- Abbott$80
- Abiomed$51
- E.r. Squibb & Sons, L.L.C.$47
- plus $258 from 11 others
What the payments were for
- Food & beverage$1,236100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 27 | $624 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $95 |
| Medtronic(2 entities) | 4 | $80 |
| Abbott | 4 | $80 |
| Abiomed | 1 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Pfizer | 3 | $47 |
| Cardinal Health 200 LLC | 3 | $46 |
| Novartis | 2 | $38 |
| Philips North America LLC | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Terumo Medical Corporation | 1 | $16 |
| Braemar Manufacturing, LLC | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
| Amgen | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $11 |
How this compares
$1,236 in reported general payments places this provider in the 10th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Riverview
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
- Miguel DiazHialeah$383K
- Douglas EbersoleLakeland$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.